These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36977788)

  • 21. Management of schizophrenia with substance use disorders.
    Lybrand J; Caroff S
    Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizophrenia drug gets negative results for negative symptoms.
    Kingwell K
    Nat Rev Drug Discov; 2014 Apr; 13(4):244-5. PubMed ID: 24687052
    [No Abstract]   [Full Text] [Related]  

  • 23. Challenge to atypical antipsychotic drug effect on cognition.
    Carpenter WT; Conley RR
    Am J Psychiatry; 2007 Dec; 164(12):1910-1; author reply 1911-2. PubMed ID: 18056250
    [No Abstract]   [Full Text] [Related]  

  • 24. Residual and negative symptoms in treatment with neuroleptics.
    Kane JM
    Psychopharmacol Ser; 1993; 10():131-7. PubMed ID: 8103222
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine.
    Khouzam HR
    Depress Anxiety; 2000; 11(2):80-2. PubMed ID: 10812533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are we still talking to our patients with schizophrenia?
    Keith SJ
    Am J Psychiatry; 2006 Mar; 163(3):362-4. PubMed ID: 16513853
    [No Abstract]   [Full Text] [Related]  

  • 27. [Compliance with treatment in schizophrenia and mood disorders].
    Sorvaniemi M; Kampman O
    Duodecim; 2000; 116(3):277-84. PubMed ID: 11764451
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fewer adverse effects! Treatment with atypical neuroleptics].
    Müller N; Riedel M
    Pharm Unserer Zeit; 2002; 31(6):558-65. PubMed ID: 12481513
    [No Abstract]   [Full Text] [Related]  

  • 29. Olanzapine for primary negative symptoms.
    Licht RW
    Am J Psychiatry; 1998 Aug; 155(8):1133-4. PubMed ID: 9699711
    [No Abstract]   [Full Text] [Related]  

  • 30. Olanzapine and negative and positive symptoms.
    Rifkin A
    Am J Psychiatry; 2001 May; 158(5):825. PubMed ID: 11329430
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia.
    Jhamnani K; Shivakumar V; Kalmady S; Rao NP; Venkatasubramanian G
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E06-7. PubMed ID: 23487204
    [No Abstract]   [Full Text] [Related]  

  • 32. Positive and negative symptoms during neuroleptic treatment.
    Kramer MS
    Biol Psychiatry; 1991 Mar; 29(6):620-1. PubMed ID: 1675891
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?
    Buckley PF; Stahl SM
    Acta Psychiatr Scand; 2007 Feb; 115(2):93-100. PubMed ID: 17244172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A model of integrated therapy in the case of mutism in a chronic schizophrenic].
    Gattoni T
    Minerva Psichiatr; 1992; 33(4):335-8. PubMed ID: 1363675
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of schizophrenia negative symptoms: future prospects.
    Erhart SM; Marder SR; Carpenter WT
    Schizophr Bull; 2006 Apr; 32(2):234-7. PubMed ID: 16492797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic-resistant schizophrenics.
    Murray JB
    J Psychol; 1989 Jan; 123(1):69-78. PubMed ID: 2564435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptomatic presentation and initial treatment for schizophrenia in children and adolescents.
    Correll CU
    J Clin Psychiatry; 2010 Nov; 71(11):e29. PubMed ID: 21114942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schizophrenia and antipsychotic medication--better adherence, better outcomes?
    Staring AB; Van der Gaag M; Mulder CL
    Schizophr Res; 2013 Dec; 151(1-3):296-7. PubMed ID: 24238966
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychostimulant Use in Schizophrenia for Treatment of Negative Symptoms and Weight Loss.
    Wahid N; Kim JJ; Bota RG
    Prim Care Companion CNS Disord; 2017 Jul; 19(4):. PubMed ID: 28767206
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success].
    Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.